Items where authors include "Shaw, G."

Article

Patel, P., Alghamdi, A., Shaw, G. et al. (18 more authors) (2023) Development of a personalised device for systemic magnetic drug targeting to brain tumours. Nanotheranostics, 7 (1). pp. 102-116. ISSN 2206-7418

Shaw, G., Cavalcante, L., Giles, F.J. et al. (1 more author) (2022) Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells. Journal of Hematology & Oncology, 15. 134. ISSN 1756-8722

Thompson, L., Hill, M., Lecky, F. orcid.org/0000-0001-6806-0921 et al. (1 more author) (2021) Defining major trauma : a Delphi study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 29 (1). 63.

Asim, M., Tarish, F., Zecchini, H.I. et al. (27 more authors) (2017) Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nature Communications, 8 (1). 374. ISSN 2041-1723

Godena, V.K., Brookes-Hocking, N., Moller, A. et al. (6 more authors) (2014) Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nature Communications, 5. 5245 . ISSN 2041-1723

Walmsley, S. R., Chilvers, E. R., Thompson, A. A. et al. (16 more authors) (2011) Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. The Journal of clinical investigation, 121 (3). pp. 1053-63. ISSN 1558-8238

Chamberlain, J., Francis, S., Brookes, Z. et al. (5 more authors) (2009) Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. Plos One, 4 (4). Art No.e5073. ISSN 1932-6203